Oral Hearings schedule

The Review's oral hearings provide an opportunity for those invited to attend to tell us what they think we need to know, and to answer the Review's questions.

Oral hearings are not open to the public but the proceedings will be video recorded and available via the Review's website shortly after each session.

We expect that hearings will run from November 2018 to March 2019, though that timeframe may be extended.

Below is the list of hearings currently scheduled. Details of later hearings will be available here in due course

20th November

  • Session 1: FACSaware
  • Session 2: Young people affected by valproate
  • Session 3: Organisation for Anti-Convulsant Syndrome (OACS) and OACS Ireland

21st November

  • Session 1: Mashed up by Mesh
  • Session 2: Mesh UK Charitable Trust
  • Session 3: Meshies United Group UK
  • Session 4: Mesh Ireland - did not attend, re-arranged for 19th March
  • Session 5: Welsh Mesh Support Group
  • Session 6: Scottish Mesh Survivors

26th November

  • Session 1: Association for Children Damaged by Hormone Pregnancy Tests (ACDHPT)
  • Session 2: Jason Farrell
  • Session 3: Dr Jesse Olszynko-Gryn
  • Session 4: INFACT and Fetal Anti-Convulsant Syndrome Association (FACSA)
  • Session 5: Dr Rebecca Bromley, Professor Jill Clayton-Smith and Professor Peter Turnpenny

27th November

  • Session 1: Sling the Mesh
  • Session 2: Dr Wael Agur and Ms Suzie Elneil
  • Session 3: Myra Robson
  • Session 4: Professor Carl Heneghan
  • Session 5: Professor Carl Heneghan
  • Session 6: Professor John Abraham
  • Session 7: Professor Neil Vargesson

10th January

  • Session 1: Dr Frances Elmslie
  • Session 2: Action against Medical Accidents (AvMA), Private Healthcare Information Network (PHIN), NHS Resolution
  • Session 3: Medicines and Healthcare products Regulation Agency (MHRA)*, Drug Safety Research Unit (DSRU)
  • Session 4: General Medical Council (GMC), General Pharmaceutical Council (GPhC)
  • Session 5: Professional Standards Authority (PSA)

*Adverse Event reporting only. MHRA will appear at a later date to discuss regulatory matters.

18th January

  • Session 1: Sanofi

23rd January

  • Session 1: Dr Vincent Argent
  • Session 2: Royal College of General Practitioners (RCGP)
  • Session 3: FEG Textiltechnik
  • Session 4: Dr Mark Slack

28th January

  • Session 1: Expert Working Group on Hormonal Pregnancy Tests
  • Session 2: Association of British Neurologists (ABN) & Royal College Psychiatrists (RCPsych)
  • Session 3: Royal Pharmaceutical Society (RPS)
  • Session 4: Professor Shakila Thangaratinam

7th February

  • Session 1: British Pain Society
  • Session 2: Chartered Society of Physiotherapy
  • Session 3: British Association of Urological Surgeons (BAUS), British Society of Urogynaecology (BSUG), Pelvic Floor Society (PFS)
  • Session 4: Royal College of Surgeons (RCS)
  • Session 5: Royal College of Obstetricians and Gynaecologists (RCOG)

14th February

  • Session 1: Association for Children Damaged by Hormone Pregnancy Tests (ACDHPT)
  • Session 2: National Institute for Health and Care Excellence (NICE)
  • Session 3: NHS England

27th February

  • Medicines and Healthcare products Regulation Agency (MHRA)

5th March

  • Session 1:
    • NHS Digital
    • Healthcare Quality Improvement Partnership (HQIP)
    • Private Healthcare Information Network (PHIN)
    • Professor Justin Keen
  • Session 2:
    • The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS)
    • National Joint Registry (NJR)
  • Session 3: Association of British HealthTec Industries (ABHI)
  • Session 4: NHS Resolution

14th March

  • Session 1: General Medical Council (GMC)
  • Session 2: UK Epilepsy and Pregnancy Register
  • Session 3: vCJD Trust

19th March

  • Session 1: Thalidomide Trust
  • Session 2: Mesh Ireland

26th March

  • Session 1: Care Quality Commission (CQC)
  • Session 2: NHS Improvement
  • Session3: Independent Healthcare Providers Network (IHPN)

16th April

  • Session 1:
    • Pelvic Floor Society
    • The British Association of Urological Surgeons (BAUS) - did not attend
    • British Society of Urogynaecology (BSUG)
  • Session 2: MESH SPECIALIST CENTRES
    • South Tees Hospitals NHSFT
    • Epsom and St Helier University Hospitals NHS Trust - did not attend, rearranged for 23rd April
    • Central Manchester University Hospitals NHSFT
  • Session3:
    • Epilepsy Society
    • Epilepsy Action

23rd April

  • MESH SPECIALIST CENTRES:
    King’s College Hospital NHSFT
    Oxford University Hospitals NHSFT
    Epsom and St Helier University Hospitals NHS Trust

2nd May

  • Department of Health and Social Care

14th May

  • Session 1: APPG on Surgical Mesh Implants - Rearranged for 28th May
  • Session 2: Hormone Pregnancy Tests APPG
  • Session 3: Valproate and Other Anti-Epileptic Drugs in Pregnancy APPG

20th May

  • Session 1: Welsh Mesh Survivors
  • Session 2: Mesh Ireland
  • Session 3: Association of Children Damaged by Hormone Pregnancy Tests (ACDHPT)
  • Session 4: Scottish Mesh Survivors

21st May

  • Session 1: TVT Messed Up Mesh - Unable to attend
  • Session 2: Mashed Up By Mesh - Unable to attend
  • Session 3: Meshies United Group UK - Unable to attend
  • Session 4: Sling the Mesh
  • Session 5: Mesh UK Charitable Trust

22nd May

  • Session 1: INFACT
  • Session 2: Young People Affected by Valproate
  • Session 3: FACSaware
  • Session 4: OACS, OACS Ireland
  • Session 5: Valproate Victims